Skip to content

Author

Su-Hsin Chang

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Oct 2026

Abstract A091: Improving access and affordability in multiple myeloma care: Patient and provider perspectives

Multiple myeloma (MM) is a complex, costly hematologic cancer with well-documented health disparities in patient outcomes. We conducted a qualitative study to capture stakeholders’ perspectives on care barriers and potential solutions to inform interventions that improve accessibility and affordability, particula...

Meera Muthukrishnan, Shelbie Fishman, R. Vij et al. · 0 citations
Open access Sep 2026

Real-World Efficacy and Safety of Standard-of-Care Chimeric Antigen Receptor T-Cell (CART) and Bispecific T-Cell Engager (TCE) Therapies in Relapsed/Refractory Multiple Myeloma (RRMM).

We aimed to evaluate the real-world (RW) efficacy and safety of standard-of-care CART versus TCE therapies in relapsed/refractory myeloma (RRMM), to assess utilization, outcomes, and tolerability of these therapies in a RW oncology in the US. Data were derived from the US-based, electronic health record-derived deident...

Poy Theprungsirikul, Rong Wang, Su-Hsin Chang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.